Cresco Labs Inc. 提交 6-K 文件,附第三季度财务报表及业绩公告
6-K - Cresco Labs Inc. (0001832928) (Filer)
Cresco Labs Inc. 于 11 月 6 日提交 6-K 文件,附有截至 9 月 30 日的三个月及九个月期间、涵盖 2026 年和 2025 年的未经审计简明中期合并财务报表与管理层讨论和分析。文件还收录了 11 月 6 日发布的新闻稿。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16
Under the Securities Exchange Act of 1934
For the month of November, 2026
000-56241
(Commission File Number)
Cresco Labs Inc.
(Exact name of Registrant as specified in its charter)
600 W. Fulton Street, Suite 800
Chicago, IL 60661
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
| Exhibit Index | ||||||||
| Exhibit No. | Description | |||||||
Unaudited Condensed Interim Consolidated Financial Statements for the three and nine months ended September 30, 2026 and 2025 | ||||||||
Management Discussion and Analysis of Financial Condition and Results of Operations for the three and nine months ended September 30, 2026 and 2025 | ||||||||
News Release dated November 6, 2026 | ||||||||
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| CRESCO LABS INC. | ||||||||
Date: November 6, 2026 | By: | /s/ Charles Bachtell | ||||||
| Charles Bachtell | ||||||||
| Chief Executive Officer | ||||||||
来源:SEC EDGAR · 本站存档